The Food and Drug Administration released safety guidance for approving coronavirus vaccine candidates Tuesday, requiring proof that they are 50% more effective than the placebo in preventing infection.

The guidance applies to vaccine manufacturers seeking full regulatory approval, but the FDA said a vaccine could be introduced to the public under emergency use authorization, a less stringent safety designation.